2026 Q2 -tulosraportti
14 päivää sitten
‧32 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 798 | - | - | ||
| 165 | - | - | ||
| 6 | - | - | ||
| 990 | - | - | ||
| 1 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 19.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 21.5. | ||
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 |
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·23 min sittenBioPorto: 2nd quarter delivered on all parameters in the long-term plan https://www.inderes.se/research/bioporto-q2-levererade-pa-alla-parametrar-i-langtidsplanen?utm_source=nordnet&utm_medium=integration
·5 t sittenBioporto will apparently only become cash POSITIVE in 2028, and the really big capital gain will probably also only come in 2028 and maybe by selling the company....But does anyone have a guess on how our share price development will be along the way, because it must probably be gradually factored in that we are getting closer and closer to reaching the goal.....so are there guesses on the share price development in e.g. during 2027? And after that 2028
The market is looking for real progress and will trade based on those signals. If the market becomes convinced that the case can yield returns, then the price increase will come when that signal is received by the market. Until a clear signal comes, the price will fluctuate around here at this level. I doubt that you can adjust the price development according to a benchmark in 2028, where management has set an expectation for a financial result. It may also be that there will be more delays and more reductions of the financial target. There have been many negative adjustments, and it is probably not unthinkable that there will be more.- ·27.8. · MuokattuMuldyr, you made me doubt if I had also understood it correctly, whether Bioporto has closed agreements with 54 hospitals in H1 2026. Therefore, I took the time to watch the webcast again. I wanted to be absolutely sure that it is 54 hospitals Bioporto has closed agreements with. It was correctly understood. 54 units in 2026. I have inserted a link to the webcast; if you only want to spend time hearing KW say how many hospitals they have closed agreements with in the first half of 2026, you can just set the cursor to 11:14 https://www.inderes.dk/videos/bioporto-praesentation-af-h1-2026-resultaterJFJ2209 I expect that we in the future will have a good tone towards each other. I will therefore suggest that you and others in the future, as an example, write I do not agree with what you say, or I disagree or something third, which is respectful. No, I am not deleting the post, for that is what I have understood, and I have no problems with writing something. I have not understood, but I have a problem with being called an idiot.
- ·25.8.Well, I don't know about you, but I overlooked that Bioporto expects KDIGO to finish finalizing the documents in Q4. KDIGO (Kidney Disease: Improving Global Outcomes) published an updated draft clinical practice guideline for acute kidney injury (AKI) and acute kidney disease (AKD) at the end of March 2026. The company has provided feedback on the draft guideline and expects the final guideline to be published at the end of 2026. https://www.inderes.dk/en/releases/bioporto-announces-interim-results-for-the-second-quarter-and-first-half-of-2026
3D, on a slide from the webcast it appears that a total of 10 new hospitals have been added this year. 4 in Q1 + 6 in Q2. - 24.8.Julkaisu on poistettu.It's not me who deleted this post, To Muldyr and JFJ2209, thank you for making me aware that there has been misleading information from management's side. This post clearly showed that one thing was stated in the financial report, and what was said in the webcast was a completely different story. It is unheard of and illegal to provide asymmetric and misleading information to shareholders. What is stated in the financial reports and what is said during the webcast must match, and it does not. In the webcast, shareholders were informed that Bioporto had closed agreements with 54 hospitals in 2026. This was repeated, so it was not a slip of the tongue. Also, that KW and CB feel confident because they are sure that they will close 60+ agreements in 2026. In the financial report, it is detailed. That Bioporto started 2026 with 44 hospitals in their customer database. And that they have closed agreements with 10 hospitals in 2026. Finally, that Bioporto's goal is that, including the 44 hospitals, they will have more than 60+ in total in their customer database. This means that these 60+ hospitals include the 44 hospitals they already had from 2025. It is very illegal that what they say in the webcast is directly misleading information, and furthermore, it is also asymmetric information. This means again that the people who bought shares in Bioporto believing that Bioporto had closed agreements with 54 hospitals in 2026 acted based on misleading information from management's side. I made Bioporto aware of the above on Friday and asked them to correct this misleading and asymmetric information. I wanted to give them a chance to correct it. They haven't done so, I haven't heard or seen anything, so I'm writing this after the stock market close. As I wrote to JFJ2209, I have no problem speaking up if there's something I don't understand, and when I figure it out, it should naturally also be stated publicly. Whether you can use this information or not is up to you.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 151 504 | 151 504 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 151 504 | 151 504 | 0 | 0 |
2026 Q2 -tulosraportti
14 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 min sittenBioPorto: 2nd quarter delivered on all parameters in the long-term plan https://www.inderes.se/research/bioporto-q2-levererade-pa-alla-parametrar-i-langtidsplanen?utm_source=nordnet&utm_medium=integration
- ·5 t sittenBioporto will apparently only become cash POSITIVE in 2028, and the really big capital gain will probably also only come in 2028 and maybe by selling the company....But does anyone have a guess on how our share price development will be along the way, because it must probably be gradually factored in that we are getting closer and closer to reaching the goal.....so are there guesses on the share price development in e.g. during 2027? And after that 2028The market is looking for real progress and will trade based on those signals. If the market becomes convinced that the case can yield returns, then the price increase will come when that signal is received by the market. Until a clear signal comes, the price will fluctuate around here at this level. I doubt that you can adjust the price development according to a benchmark in 2028, where management has set an expectation for a financial result. It may also be that there will be more delays and more reductions of the financial target. There have been many negative adjustments, and it is probably not unthinkable that there will be more.
- ·27.8. · MuokattuMuldyr, you made me doubt if I had also understood it correctly, whether Bioporto has closed agreements with 54 hospitals in H1 2026. Therefore, I took the time to watch the webcast again. I wanted to be absolutely sure that it is 54 hospitals Bioporto has closed agreements with. It was correctly understood. 54 units in 2026. I have inserted a link to the webcast; if you only want to spend time hearing KW say how many hospitals they have closed agreements with in the first half of 2026, you can just set the cursor to 11:14 https://www.inderes.dk/videos/bioporto-praesentation-af-h1-2026-resultaterJFJ2209 I expect that we in the future will have a good tone towards each other. I will therefore suggest that you and others in the future, as an example, write I do not agree with what you say, or I disagree or something third, which is respectful. No, I am not deleting the post, for that is what I have understood, and I have no problems with writing something. I have not understood, but I have a problem with being called an idiot.
- ·25.8.Well, I don't know about you, but I overlooked that Bioporto expects KDIGO to finish finalizing the documents in Q4. KDIGO (Kidney Disease: Improving Global Outcomes) published an updated draft clinical practice guideline for acute kidney injury (AKI) and acute kidney disease (AKD) at the end of March 2026. The company has provided feedback on the draft guideline and expects the final guideline to be published at the end of 2026. https://www.inderes.dk/en/releases/bioporto-announces-interim-results-for-the-second-quarter-and-first-half-of-20263D, on a slide from the webcast it appears that a total of 10 new hospitals have been added this year. 4 in Q1 + 6 in Q2.
- 24.8.Julkaisu on poistettu.It's not me who deleted this post, To Muldyr and JFJ2209, thank you for making me aware that there has been misleading information from management's side. This post clearly showed that one thing was stated in the financial report, and what was said in the webcast was a completely different story. It is unheard of and illegal to provide asymmetric and misleading information to shareholders. What is stated in the financial reports and what is said during the webcast must match, and it does not. In the webcast, shareholders were informed that Bioporto had closed agreements with 54 hospitals in 2026. This was repeated, so it was not a slip of the tongue. Also, that KW and CB feel confident because they are sure that they will close 60+ agreements in 2026. In the financial report, it is detailed. That Bioporto started 2026 with 44 hospitals in their customer database. And that they have closed agreements with 10 hospitals in 2026. Finally, that Bioporto's goal is that, including the 44 hospitals, they will have more than 60+ in total in their customer database. This means that these 60+ hospitals include the 44 hospitals they already had from 2025. It is very illegal that what they say in the webcast is directly misleading information, and furthermore, it is also asymmetric information. This means again that the people who bought shares in Bioporto believing that Bioporto had closed agreements with 54 hospitals in 2026 acted based on misleading information from management's side. I made Bioporto aware of the above on Friday and asked them to correct this misleading and asymmetric information. I wanted to give them a chance to correct it. They haven't done so, I haven't heard or seen anything, so I'm writing this after the stock market close. As I wrote to JFJ2209, I have no problem speaking up if there's something I don't understand, and when I figure it out, it should naturally also be stated publicly. Whether you can use this information or not is up to you.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 798 | - | - | ||
| 165 | - | - | ||
| 6 | - | - | ||
| 990 | - | - | ||
| 1 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 19.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 21.5. | ||
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 151 504 | 151 504 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 151 504 | 151 504 | 0 | 0 |
2026 Q2 -tulosraportti
14 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 19.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 21.5. | ||
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 min sittenBioPorto: 2nd quarter delivered on all parameters in the long-term plan https://www.inderes.se/research/bioporto-q2-levererade-pa-alla-parametrar-i-langtidsplanen?utm_source=nordnet&utm_medium=integration
- ·5 t sittenBioporto will apparently only become cash POSITIVE in 2028, and the really big capital gain will probably also only come in 2028 and maybe by selling the company....But does anyone have a guess on how our share price development will be along the way, because it must probably be gradually factored in that we are getting closer and closer to reaching the goal.....so are there guesses on the share price development in e.g. during 2027? And after that 2028The market is looking for real progress and will trade based on those signals. If the market becomes convinced that the case can yield returns, then the price increase will come when that signal is received by the market. Until a clear signal comes, the price will fluctuate around here at this level. I doubt that you can adjust the price development according to a benchmark in 2028, where management has set an expectation for a financial result. It may also be that there will be more delays and more reductions of the financial target. There have been many negative adjustments, and it is probably not unthinkable that there will be more.
- ·27.8. · MuokattuMuldyr, you made me doubt if I had also understood it correctly, whether Bioporto has closed agreements with 54 hospitals in H1 2026. Therefore, I took the time to watch the webcast again. I wanted to be absolutely sure that it is 54 hospitals Bioporto has closed agreements with. It was correctly understood. 54 units in 2026. I have inserted a link to the webcast; if you only want to spend time hearing KW say how many hospitals they have closed agreements with in the first half of 2026, you can just set the cursor to 11:14 https://www.inderes.dk/videos/bioporto-praesentation-af-h1-2026-resultaterJFJ2209 I expect that we in the future will have a good tone towards each other. I will therefore suggest that you and others in the future, as an example, write I do not agree with what you say, or I disagree or something third, which is respectful. No, I am not deleting the post, for that is what I have understood, and I have no problems with writing something. I have not understood, but I have a problem with being called an idiot.
- ·25.8.Well, I don't know about you, but I overlooked that Bioporto expects KDIGO to finish finalizing the documents in Q4. KDIGO (Kidney Disease: Improving Global Outcomes) published an updated draft clinical practice guideline for acute kidney injury (AKI) and acute kidney disease (AKD) at the end of March 2026. The company has provided feedback on the draft guideline and expects the final guideline to be published at the end of 2026. https://www.inderes.dk/en/releases/bioporto-announces-interim-results-for-the-second-quarter-and-first-half-of-20263D, on a slide from the webcast it appears that a total of 10 new hospitals have been added this year. 4 in Q1 + 6 in Q2.
- 24.8.Julkaisu on poistettu.It's not me who deleted this post, To Muldyr and JFJ2209, thank you for making me aware that there has been misleading information from management's side. This post clearly showed that one thing was stated in the financial report, and what was said in the webcast was a completely different story. It is unheard of and illegal to provide asymmetric and misleading information to shareholders. What is stated in the financial reports and what is said during the webcast must match, and it does not. In the webcast, shareholders were informed that Bioporto had closed agreements with 54 hospitals in 2026. This was repeated, so it was not a slip of the tongue. Also, that KW and CB feel confident because they are sure that they will close 60+ agreements in 2026. In the financial report, it is detailed. That Bioporto started 2026 with 44 hospitals in their customer database. And that they have closed agreements with 10 hospitals in 2026. Finally, that Bioporto's goal is that, including the 44 hospitals, they will have more than 60+ in total in their customer database. This means that these 60+ hospitals include the 44 hospitals they already had from 2025. It is very illegal that what they say in the webcast is directly misleading information, and furthermore, it is also asymmetric information. This means again that the people who bought shares in Bioporto believing that Bioporto had closed agreements with 54 hospitals in 2026 acted based on misleading information from management's side. I made Bioporto aware of the above on Friday and asked them to correct this misleading and asymmetric information. I wanted to give them a chance to correct it. They haven't done so, I haven't heard or seen anything, so I'm writing this after the stock market close. As I wrote to JFJ2209, I have no problem speaking up if there's something I don't understand, and when I figure it out, it should naturally also be stated publicly. Whether you can use this information or not is up to you.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 798 | - | - | ||
| 165 | - | - | ||
| 6 | - | - | ||
| 990 | - | - | ||
| 1 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 151 504 | 151 504 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 151 504 | 151 504 | 0 | 0 |